Skip to content

Checked

Iambic Therapeutics, Inc.

Nasdaq: IAM · Biological Products, (No Diagnostic Substances) · San Diego, CA

Last filing
10/19/2026
Filings on record
17

Company details

As reported to the SEC

SEC CIK
1997038
Stock
Nasdaq: IAM
Industry (SIC)
Biological Products, (No Diagnostic Substances) (2836)
Headquarters
5627 Oberlin Drive, Suite 120, San Diego, CA 92121
Incorporated in
Delaware
Fiscal year end (SEC record)
December 31
Phone
(626) 592-2520
Employer ID (EIN)
84-3364168

No annual XBRL financial data in U.S. dollars is available for this company. Funds, very new registrants, and some foreign companies that report in other currencies do not have it. See the filings below or on EDGAR.

Federal and state records filed under the name Iambic Therapeutics, Inc.

Matched by the company name and by the subsidiary names it lists in SEC filings and other public records, after removing endings like Inc., Corp. and Holdings. Records marked Subsidiary were filed under a subsidiary name. A subsidiary that is not listed in those records is not included, and an unrelated business with the same name can appear.

Work visa sponsorship

Certified H-1B and PERM green card filings with the Department of Labor

Employer on filingH-1BPERM
Iambic Therapeutics, Inc.San Diego, CA10

Recent filings

17 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here

Swipe the table sideways to see more columns.

FormFiledPeriod
8-KBylaws or fiscal year change, Regulation FD disclosure10/16/202610/16/2026
424B4Prospectus10/15/2026None
S-8Registration of employee stock plan shares10/15/2026None
EFFECTNotice of effectiveness10/14/2026None
CERTSEC filing10/14/2026None
8-A12BSEC filing10/13/2026None
S-1/ARegistration statement (amended)10/08/2026None
S-1Registration statement (new securities)09/21/2026None
DNotice of exempt offering (Form D)09/09/2026None
DRS/ASEC filing08/28/2026None
DRSSEC filing07/24/2026None
DNotice of exempt offering (Form D)04/08/2026None
DNotice of exempt offering (Form D)11/21/2025None
D/ANotice of exempt offering (Form D) (amended)06/06/2024None
D/ANotice of exempt offering (Form D) (amended)05/07/2024None
DNotice of exempt offering (Form D)04/25/2024None
DNotice of exempt offering (Form D)10/12/2023None
Full filing history on SEC EDGAR

29 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Iambic Therapeutics, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.

Other biological products, (no diagnostic substances)

All in this industry

Swipe the table sideways to see more columns.

CompanyHeadquartersRevenueNet income
Amgen IncAMGNThousand Oaks, CA$36.75B$7.71B
Gilead Sciences, Inc.GILDFoster City, CA$29.44B$8.51B
Biogen Inc.BIIBCambridge, MA$9.89B$1.29B
Neurocrine Biosciences IncNBIXSan Diego, CA$2.86B$478.6M
Exelixis, Inc.EXELAlameda, CA$2.32B$782.6M
Qiagen N.V.QGENPl Venlo, Netherlands$2.09B$424.9M
Moderna, Inc.MRNACambridge, MA$1.94B-$2.82B
Halozyme Therapeutics, Inc.HALOSan Diego, CA$1.4B$316.9M

Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.

Frequently asked questions

What is Iambic Therapeutics, Inc.'s CIK number?
Iambic Therapeutics, Inc.'s SEC Central Index Key (CIK) is 1997038.
What is Iambic Therapeutics, Inc.'s stock ticker?
Iambic Therapeutics, Inc. trades as Nasdaq: IAM.
When does Iambic Therapeutics, Inc.'s fiscal year end?
Iambic Therapeutics, Inc.'s fiscal year end on file with the SEC is December 31.
Where is Iambic Therapeutics, Inc. headquartered?
Iambic Therapeutics, Inc.'s principal executive office on file with the SEC is in San Diego, CA.
Does Iambic Therapeutics, Inc. sponsor H-1B visas?
Department of Labor records show 1 certified H-1B filings and 0 certified PERM filings under the name Iambic Therapeutics, Inc.

Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026